Osteoblast Precursors, but Not Mature Osteoblasts, Move into Developing and Fractured Bones along with Invading Blood Vessels  by Maes, Christa et al.
Developmental Cell
ArticleOsteoblast Precursors, but Not Mature Osteoblasts,
Move into Developing and Fractured Bones
along with Invading Blood Vessels
Christa Maes,1,2 Tatsuya Kobayashi,1 Martin K. Selig,3 Sophie Torrekens,2 Sanford I. Roth,3 Susan Mackem,4
Geert Carmeliet,2 and Henry M. Kronenberg1,*
1Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
2Department of Experimental Medicine and Endocrinology, K.U. Leuven, Leuven B-3000, Belgium
3Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
4Cancer and Developmental Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA
*Correspondence: hkronenberg@partners.org
DOI 10.1016/j.devcel.2010.07.010SUMMARY
During endochondral bone development, the first
osteoblasts differentiate in the perichondrium sur-
rounding avascular cartilaginous rudiments; the
source of trabecular osteoblasts inside the later bone
is, however, unknown. Here, we generated tamox-
ifen-inducible transgenic mice bred to Rosa26R-
LacZ reporter mice to follow the fates of stage-selec-
tive subsets of osteoblast lineage cells. Pulse-chase
studies showed that osterix-expressing osteoblast
precursors, labeled in the perichondrium prior to
vascular invasion of the cartilage, give rise to trabec-
ular osteoblasts, osteocytes, and stromal cells inside
the developing bone. Throughout the translocation,
some precursors were found to intimately associate
with invading blood vessels, in pericyte-like fashion.
A similar coinvasion occurs during endochondral
healing of bone fractures. In contrast, perichondrial
mature osteoblasts did not exhibit perivascular local-
ization and remained in the outer cortex of devel-
oping bones. These findings reveal the specific
involvement of immature osteoblast precursors in
the coupled vascular and osteogenic transformation
essential to endochondral bone development and
repair.
INTRODUCTION
Most mammalian bones develop through endochondral ossifi-
cation. This process depends on the coordinate proliferation,
differentiation, and interaction of various cell types but ultimately
relies on osteoblast lineage cells for the actual synthesis and
mineralization of the bone matrix. The origin of osteoblasts
and osteogenic stromal cells in vivo is, however, incompletely
understood.
At the start of endochondral ossification, mesenchymal
condensations that prefigure the future long bones first develop
into cartilage. When cells in the central area differentiate intoDevelophypertrophic chondrocytes, osteoblasts appear in the sur-
rounding perichondrium and generate the ‘‘bone collar,’’ the
provisional bone cortex. At this time, the initial vascular invasion
of the cartilaginous template occurs, triggering the formation of
the primary ossification center inside the bone (see Figure 1A).
Endothelial cells and osteoclasts first accumulate in the peri-
chondrial region and are attracted to invade and erode the carti-
lage (Karsenty and Wagner, 2002; Kronenberg, 2007). Concom-
itantly, osteoblasts and marrow cells populate the newly
excavated, highly vascularized area.
Osteoblasts differentiate from mesenchymal progenitors that
express Runx2, a transcription factor required for full osteo-
blastic differentiation (Nakashima et al., 2002; Komori et al.,
1997; Otto et al., 1997). Osterix (Osx), genetically downstream
of Runx2, is another early transcription factor required for osteo-
blastogenesis (Nakashima et al., 2002). As they further differen-
tiate, osteoblasts produce matrix proteins, including the main
bone constituent, type I collagen (Col1). Mature osteoblasts
that become embedded in the bone matrix differentiate into
osteocytes (Marie, 2008; Karsenty and Wagner, 2002; see
Figure 1A).
Fusion of Cre recombinase to a modified estrogen receptor
ligand-binding domain (ERt) allows the temporal induction of
its activity by administration of tamoxifen or 4-hydroxytamoxifen
(4OHTam) (Metzger et al., 1995). The clearance of tamoxifen
from the cell mediates the return of the CreERt complex to the
inactive state, thus creating a window of time for gene modula-
tion (Feil et al., 1996). A conditional reporter gene, such as the
Rosa26R b-galactosidase (LacZ) transgene (Soriano, 1999),
can indicate the recombination by the blue staining of the cell
with the LacZ substrate 4-chloro-3-indolyl-b-D-galactopyrano-
side (X-gal). Thus, this system allows genetic marking of
CreERt-expressing cells at the time of tamoxifen injection, and
the subsequent tracing of these cells and their progeny (see
Maes et al., 2007 and references therein).
Here, we used the CreERt system to develop mouse models
for osteoblast lineage tracing in vivo. By employing the Osx-
and Collagen I(a1) (Col1) gene promoters, we could label and
follow stage-selective osteogenic cells during bone develop-
ment. Our data reveal that specific pools of osteoblast lineage
cells display different fates and capacities to initiate new sites
of bone formation.mental Cell 19, 329–344, August 17, 2010 ª2010 Elsevier Inc. 329
Figure 1. Transgenic Mice with Inducible CreERt Expression in Osteoblast Lineage Cells
(A) Simplified representation (top) of the line of progression of osteoblast (OB) differentiation and the typical gene product by which each stage is characterized
(orange, below). The Osx-CreERt and Col1(3.2 kb)-CreERt transgenes employed in this study start to be expressed in osteoblast precursors and mature oste-
oblasts, respectively. Schematic outline (bottom) of the initiation of bone formation during development, occurring between E14 and E16 in the stylopod and
zeugopod bones of mice. The initial invasion of the cartilaginous bone model is associated with its transformation into the primary ossification center (POC)
that contains bone trabeculae and is surrounded by cortical bone. HC, hypertrophic cartilage.
(B) Whole-mount X-gal staining of E14.5 Osx-CreERt embryos carrying a Rosa26R reporter transgene. (left to right) Embryos unexposed to 4OHTam or not
carrying the Osx-CreERt transgene, Alizarin red mineralization staining and corresponding pattern of LacZ activity in Osx-CreERt(Tg/) embryos exposed to
4OHTam at E13.5. The mandible became disconnected from the embryo proper. Magnifications (right) highlight X-gal staining in the bony regions of the ribs,
calvaria and hind limb (HL).
(C) X-gal staining of Col1-CreERt(Tg/) embryos harvested similarly at E14.5 after 4OHTam exposure at E13.5. Right, magnified ribs and HL.
(D) E15.5 Osx- and Col1-CreERt(Tg/) embryos injected with 4OHTam at E13.5, andmagnified HL and forelimb (FL). Red arrows, reduced staining in the ribs and
HL of Col1-CreERt embryos, compared with Osx-CreERt embryos.
See also Figure S1 on the generation and characterization of the osteoblastic CreERt mice.
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CreERt Mice Driven by Stage-Specific, Osteoblast
Lineage Promoters
Osx-CreERt and Col1-CreERt mice were generated (see
Supplemental Experimental Procedures available online) and330 Developmental Cell 19, 329–344, August 17, 2010 ª2010 Elseviecrossed to Rosa26R LacZ reporter mice (Soriano, 1999)
(Figure S1A). X-gal staining of the progeny retrieved from preg-
nant mice injected with 4OHTam at specific times identified
cells that had undergone CreERt-mediated recombination and
the descendants thereof (Figure S1B). To assess the fates of
osteoblast lineage cells originating in the perichondrium, wer Inc.
Figure 2. Perichondrial Osteoblast Lineage Cells Marked by Osx- or Col1-CreERt Expression Display Differential Fates in Developing Bones
(A) Osx-CreERt (top) andCol1-CreERt (bottom) humerus sections ofmice pulsedwith 4OHTamat E13.5 and sacrificed at E14.5 (left) or at E16.5 (right) and stained
for X-gal and eosin or BrdU (far left; arrowheads indicate single LacZ+ cells, arrows point at LacZ+/BrdU+ double-positive cells). Scale bars, 100 mm.
(B and C) Quantification of the perichondrial labeling (B) and the proliferation index of the labeled cells (C) in Osx- and Col1-CreERt(Tg/) mice at E14.5.
The number of LacZ+ cells and the percentage that additionally stained positive for BrdU were determined in a defined region, encompassing the central portion
of the perichondrium corresponding to the black boxed area in (A). Bars, mean ± SEM; n = 3.
(D and E) Distribution (D) and total number (E) of traced Osx/LacZ+ and Col1/LacZ+ cells at E16.5. Cells were counted in fixed cortical and trabecular bone areas
(blue squares in A). ***p < 0.001 for comparison between genotypes; #p < 0.001 between locations. Bars, mean ± SEM; n = 5–9.
See also Figure S2 on the lineage tracing kinetics of the system.
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primary ossification center, a process initiating at or beyond
E14.5 (Figure 1A). We first confirmed that the CreERt-activityDevelopwas ligand-dependent and specific throughout embryogenesis.
In the absence of 4OHTam, no leaky recombination occurred in
either of the mouse lines, as evidenced by the lack of X-galmental Cell 19, 329–344, August 17, 2010 ª2010 Elsevier Inc. 331
Figure 3. Colabeling of Osx-CreERt-Expressing Chondrocytes Does Not Contribute Detectably to the Trabecular Osteoblast Pool
(A) Growth cartilage of the proximal humerus on 3 successive days (d1–d3) after giving 4OHTam at E13.5. Osx/LacZ+ cells are detected in the (pre-)hypertrophic
zones (left) at d1, but not in the round chondrocyte zone (right). FewOsx/LacZ+ hypertrophic chondrocytes remain at d2 (bracket). By d3, the cartilage is devoid of
blue cells, while Osx/LacZ+ cells are abundant in the metaphysis beyond the chondro-osseous junction (asterisk-marked red bracket).
(B) X-gal staining of E15.5 Col2-CreERt embryos either or not exposed to 4OHTam at E14.5. Note cartilage-confined X-gal staining, complementing Alizarin red
staining.
(C) Col2-CreERt humeri stained by X-gal at d1 and d3 after 4OHTam at E14.5. Note cartilage-specific labeling at d1 and a more complex staining pattern by d3,
analyzed in detail in the indicated areas in (D). Scale bar, 200 mm.
(D) SafraninO and eosin staining (upper left) on consecutive d1 sections showing abundant Col2/LacZ+ cells in the immature cartilage, infiltration in the hyper-
trophic layer (bracket), and absence from the perichondrium (red arrowheads). Increased hypertrophic and perichondrial labeling at d2 (upper right), including
stretched cells near the cartilage-perichondrium interface, arranged perpendicular to the bulk of the more central chondrocytes (black arrows). (Lower panels)
(d3) Area 1 (rotated) and 10 (as indicated in C, withmagnified views on the right) showing Col2/LacZ+ cells at the cartilage-perichondrium interface (arrows) and on
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cific LacZ-activity was seen in the skeleton of embryos lacking
the Osx- or Col1-CreERt transgene (Figure 1B; data not
shown).
When pregnant mice were pulsed with 4OHTam at E13.5, both
Osx-CreERt(Tg/) and Col1-CreERt(Tg/) embryos showed
intense X-gal staining after sacrifice at E14.5 (Figures 1B and
1C). Macroscopic and histological analysis confirmed the
skeleton-specificity of the induced LacZ expression (Figures
S1C–S1F). X-gal staining in E14.5 Osx-CreERt(Tg/) embryos
that received 4OHTam at E13.5 was manifest in the mandible,
the lateral calvarial bones, the proximal part of the ribs and
the proximal limb bones (Figure 1B), whereas time-matched
Col1-CreERt(Tg/) embryos showed roughly this pattern but
a reduced distribution throughout the skeleton (Figure 1C,
note, for instance, the absence of staining in the hind limbs).
These observations verified the tightly tamoxifen- and Cre-
dependent LacZ activation specifically in the skeleton of Osx-
and Col1-CreERt(Tg/) embryos and also suggested subtle
differences between the mouse lines.
To further compare the labeling patterns in Osx- and Col1-
CreERt mice, we next analyzed embryos at E15.5, after pulsing
the mother at E13.5 (Figure 1D). The X-gal staining patterns
were analogous to those observed at E14.5. Hence, Col1-
CreERt(Tg/) embryos again had a reduced extent of LacZ
activity compared with Osx-CreERt(Tg/) mice (Figure 1D).
Thus, as expected, Osx-CreERt was expressed earlier in devel-
opment than Col1-CreERt.Lineage Tracing Reveals Different Fates
for Perichondrial Osteoblast Subsets In Vivo
In line with the forelimbs running developmentally ahead of the
hind limbs, the humerus, radius and ulna stained blue in Osx-
as well as Col1-CreERt(Tg/) embryos exposed to 4OHTam at
E13.5. We, therefore, focused our tracing experiments on the
humerus. Histology confirmed its cartilaginous state at E14.5
(Figure 2A). Both Osx- and Col1-CreERt(Tg/) embryos dis-
played mosaic LacZ labeling of cells in the perichondrium
(Figure 2A, left). The number of labeled cells, designated Osx/
LacZ+ and Col1/LacZ+ cells, respectively, was not significantly
different (Figure 2B) (p = 0.84). Both sets of labeled cells
contained BrdU-positive cells (Figure 2A, far left) and their
proliferation indices were not significantly different (Figure 2C)
(p = 0.16).
In order to trace the fates of the labeled cells throughout the
next steps of endochondral bone development, we needed to
define the time window of labeling and verify that no further
de novo labeling of cells occurred beyond this period. We,
therefore, assessed the kinetics of LacZ induction in the
embryos after administration of 4OHTam (Figure S2). X-gal
staining became detectable as early as 8 hr after 4OHTam
injection and its pattern of skeletal distribution remained similarthe endosteal bone surface (arrowheads). Area 2, diffuse blue coloration at the cho
eroded hypertrophic chondrocytes. Area 3, central metaphyseal regions occup
generally not blue. Representative sections of n = 3–7 forelimbs analyzed at 15–50
ing (n = 2 per time point).
See also Figure S3.
Developthereafter. By using the differential developmental timing of the
various skeletal elements as an internal clock, we could ascer-
tain that the induced activity of both Osx-CreERt (Figure S2)
and Col1-CreERt (data not shown) was fast and transient
in vivo, with an activation window of less than 24 hr following
4OHTam administration.
Interestingly, as we traced cells labeled at E13.5 for 3 days,
the staining patterns in the two transgenic mouse lines became
markedly different (Figure 2A, right). Osx/LacZ+ cells sparsely
localized along the outer cortical bone, while they abundantly
occupied the trabecular bone formed inside the shaft (Fig-
ure 2A, upper right). In sharp contrast, Col1/LacZ+ cells local-
ized almost exclusively on the cortical surfaces and were hardly
detected inside the bone cavity (Figure 2A, lower right). These
differing patterns were confirmed by quantification in desig-
nated trabecular and cortical areas (blue squares in Figure 2A):
70% of the counted Osx/LacZ+ cells were located in the
trabecular regions, in contrast to only 20% of the Col1/LacZ+
cells (Figure 2D). The total cell counts were similar between
the two mouse lines (Figure 2E), suggesting that subtle differ-
ences in the proliferative potential of the respective cell popu-
lations were unlikely to account for the observed positional
diversity. When 4OHTam was given after the formation of the
primary ossification center (at or beyond E15.5), the Col1-
CreERt transgene was capable of labeling trabecular osteo-
blasts inside the bone (not shown). These data indicate that
perichondrial osteoblast lineage cells marked by differentiation
stage-selective gene activity display differential destinies in
developing bones. Cells of the Osx/LacZ+ pool appear
predominantly to move inside the bone to the trabecular
regions, whereas Col1/LacZ+ cells predominantly remain on
the cortex.Colabeling of Osx-CreERt-Expressing Chondrocytes
Does Not Contribute Much to the Trabecular
Osteoblast Pool
Col1-CreERt labeling was exclusive to the perichondrium,
whereas Osx-CreERt(Tg/) embryos also showed mosaic
labeling in the pre- and early hypertrophic chondrocyte zones
(Figure 3A), in line with the endogenous expression of Osx in
prehypertrophic chondrocytes (Hilton et al., 2005) (see also
Figure S4A). No self-renewing population was targeted, as
Osx/LacZ+ chondrocytes completely disappeared by 3 days
postinjection (E16.5) (Figure 3A). To assess whether these cells
had died by apoptosis or had transdifferentiated into osteogenic
cells, we employed a cartilage-directed Col2-CreERt mouse line
(Nakamura et al., 2006) (Figure 3B).
This Col2-Cre(ERt) line, like many others (Hilton et al., 2007;
Sakai et al., 2001) marks both chondrocytes and perichondrial
cells and their osteoblastic descendants when active early in
bone development, probably by targeting a population of
chondro-perichondrial progenitors (Figure S3). By injectingndro-osseous interface, likely explained by residual LacZ activity released from
ied by trabecular osteoblasts (arrows) and osteocytes (arrowheads) that are
mm intervals are shown. Col2-CreERt(/) sectionswere devoid of X-gal stain-
mental Cell 19, 329–344, August 17, 2010 ª2010 Elsevier Inc. 333
Figure 4. Perichondrial Osx/LacZ+ and Col1/LacZ+ Cells Represent Increasing Stages of Osteogenic Differentiation
(A) EM methodology. Consecutive middiaphyseal, transversal thin sections analyzed by (A1) toluidine blue, (A2) X-gal, and (A3) EM were aligned. Scale bar,
50 mm. (A4), dark accumulations of X-gal deposits (arrows) as often detected among the granular ER confirmed that blue stained cells identified on A2 could
be specifically designated as X-gal+ (blue ‘‘+’’) on the EM images of the consecutive section.
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cumvented in the humerus. We stepwise traced the labeled
cells over a 3 day period. Our data (Figures 3C and 3D)
suggest that specific cells at the lateral cartilage-perichon-
drium interface contribute to the endosteal osteoblast pool
(osteoblasts on the inner surface of the cortex) (Figure 3D,
bottom, 1 and 10), but terminally matured chondrocytes do
not detectably contribute to the osteoblast/osteocyte pool
in the central metaphyseal regions beneath the growth carti-
lage (away from the endosteal surface) (Figure 3D, bottom,
2 and 3). Thus, we conclude that the osteoblasts of the
primary ossification center are primarily derived from translo-
cating perichondrial cells, as represented by the Osx/LacZ+
cells.
Differentiation Stage Selectivity of Osx/LacZ+ Cells
and Col1/LacZ+ Cells
Since perichondrial Osx/LacZ+ cells move into the bone,
whereas Col1/LacZ+ cells hardly do, these cell pools may differ
substantially. We closely examined the cells and their direct
environment shortly after labeling at E13.5 by transmission elec-
tron microscopy (EM), using immediately adjacent sections to
identify the LacZ+ cells (blue X-gal staining) within the tissue
outline (toluidine blue) (Figures 4A1–4A3) (see Experimental
Procedures). Labeled cells analyzed by EM were identified
based on their blue coloration in the consecutive thin section
throughout the study. The validity of this cell-specific alignment
of the EM and LacZ information was confirmed by the detection
of X-gal reaction product as dark cytoplasmic deposits on EM in
several of the analyzed samples (Figure 4A4).
At E14.5, perichondrial Osx/LacZ+ cells constituted a hetero-
geneous population. The majority (24/40; 60%) were immature
stromal cells displaying large nuclei, very sparse endoplasmic
reticulum (ER), and cytoplasmic extrusions, embedded in a loose
connective tissue matrix, with some adherence to cells of similar
morphology (Figure 4B1). A second class was defined as ‘‘early
osteoblasts’’ (9/40); such cells had features resembling stromal
cells but were found near collagen-containing matrix, and dis-
played no or limited active bone formation (Figure 4B2–4B200).
Only a minority of the Osx/LacZ+ cells had an appearance(B) EM images of perichondrial Osx/LacZ+ cells (blue ‘‘+’’) 1 day after 4OHTam
stromal cells (B1), early osteoblasts (B2 and boxesmagnified in B20 andB20), or pe
(V) (B3). The inset demonstrates the blueOsx/LacZ+ cell at the lightmicroscopic le
reveals a tight junction (arrow) between the ECs of the immature capillary lacking
(C) Scoring analysis by EM of Osx/LacZ+ and Col1/LacZ+ cells at 12 or 24 hr af
(D) Representative Col1/LacZ+ cells at 12 (D1) and 24 hr (D2). V, perichondrial ca
labeled whereas the Col1/LacZ+ cells present as mature, cuboidal osteoblasts. (
(arrows). (D2 and small box in D200) Mature osteoblasts. Scale bars, 2 mm.
(E) Histology at E14.5 showing the relationship between E13.5-labeled LacZ+ pe
that are unrelated to the mineralized bone, whereas Col1/LacZ+ cells are mostly lo
inset). Scale bar, 50 mm.
(F) E14.5 embryos exposed to 4OHTam at E12.5. Note X-gal staining in Osx- bu
(G) Histology of the corresponding humeri stained by Von Kossa. Col1/LacZ+ ce
(H) Representative EM images of Osx/LacZ+ cells labeled at E12.5 and analyze
connective tissue, often in close juxtaposition with capillaries (V, dotted line). Inse
matic processes (arrows) and gap junctions (asterisk).
(I) Morphological appearance of Osx/LacZ+ cells scored by EM analysis at 24 or
cells analyzed per group).
(J) E12.5-labeled Osx/LacZ+ cell counts in the cortical and trabecular bone regio
Bars, mean ± SEM; n = 2; ***p < 0.001. See also Figure S4.
Developconsistent with that of mature osteoblasts (see below). Interest-
ingly, almost 20% of the cells with stromal appearance (10% of
all Osx/LacZ+ cells examined) were found alongside perichon-
drial blood vessels. These cells attained a pronounced pericytic
localization with cellular processes enfolding the endothelial
lining of red blood cell (RBC)-filled capillaries (Figures 4B3–4B30).
A parallel analysis of Col1/LacZ+ cells performed 12 or 24 hr
after labeling revealed that none of these cells were perivascular,
pericyte-like (Figure 4C) (n = 46–47 cells examined). Instead, they
were primarily mature, matrix-secreting, and mineralizing osteo-
blasts and osteocytes, each with abundant arrays of granular
ER and/or partially or completely surrounded by osteoid matrix
and mineralized bone (Figure 4D). Routine light microscopy
confirmed these findings, as Osx/LacZ+ cells were found both
on and unrelated to the mineralized bone collar, whereas Col1/
LacZ+ cells were primarily associated with the bone surface
(Figure 4E, Von Kossa staining with black deposits denoting
mineralization).
Selective Labeling and Tracing of the Earliest
Osx-CreERt-Expressing Cells
The analysis described above confirmed our expectation that, at
E13.5, Col1-CreERt expression was associated with maturing
osteoblasts, whereas Osx-CreERt expression was associated
with awider range of osteoblast lineage cells, including immature
cells. Particularly these early cellsmay thus be responsible for the
osteogenic colonization of the primary ossification center. To test
this hypothesis, we next labeled an Osx/LacZ+ population en-
riched in immature cells. In agreement with the differential timing
of activation of the endogenous Osx- and Col1-gene promoters
(see Figures S4A–S4C), Osx-CreERt labeling was achieved at
an earlier time than Col1-CreERt labeling. Injecting 4OHTam at
E12.5was the earliest time point that led tomarked X-gal staining
of the proximal bones of the limbs inOsx-, but not in Col1-CreERt
(Tg/) embryos (Figure 4F; data not shown). Histology at E14.5
showedperichondrial labeling inOsx-CreERt limbsections,while
Col1/LacZ+ cells could barely be detected, even in the humerus
(Figure 4G). The Osx/LacZ+ cells appeared prior to bone collar
formation, as evidenced by the lack of mineralization at E13.5
(Figure S4D, left). These data suggest that giving 4OHTam at-induced labeling at E13.5, appearing as loosely focally connected immature
ricytic cells surrounding the endothelial cells (EC) of perichondrial blood vessels
vel as used throughout the study as identification criterion. The high power (B30 )
a basement membrane and containing RBCs. Scale bars, 2 mm.
ter labeling at E13.5 (40–47 cells analyzed per group).
pillary vessels. (D1) Typically, stromal and perivascular cells (asterisks) are not
D2 and large box magnified in D20) A Col1/LacZ+ osteocyte with cell dendrites
richondrial cells and the bone collar (Von Kossa, black). Note Osx/LacZ+ cells
cated on the bone surface (magnification) or embedded in the bone (arrow and
t not in Col1-CreERt hind limbs (arrows).
lls are only rarely found (red arrow). Scale bar, 100 mm.
d at E13.5, showing their appearance as immature stromal cells in the loose
t, aligned X-gal view. Bottom, magnified view of boxed area, showing cytoplas-
48 hr after labeling at E12.5, revealing the enrichment of immature cells (14–17
ns of E16.5 humeri.
mental Cell 19, 329–344, August 17, 2010 ª2010 Elsevier Inc. 335
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matured to become collagen type I-producing osteoblasts.
EM analysis confirmed that the Osx/LacZ+ pool labeled at
E12.5 consisted exclusively of cells classified morphologically
as immature stromal cells and early osteoblasts 24 hr after
labeling, only progressing to contribute to the pool of mature
osteoblasts involved in the bone collar after 48 hr (Figures 4H
and 4I). The early labeled Osx/LacZ+ pool was further enriched
in pericytic cells positioned on blood vessels (20% of the cells
screened) (Figure 4I).
We then traced these immature Osx/LacZ+ cells over the next
days (Figure S4D). As the primary ossification center developed,
blue cells progressively localized inside the bone cavity and
increasingly associated with the primary trabeculae and the
endosteal surface of the bone collar (Figure S4D). Using a quanti-
fication strategy like that used in Figure 2D, the Osx/LacZ+ cells
labeled earlier shifted even more to the primary spongiosa by
E16.5 (>80%), with less than 20% of the cells residing in the
corticalareas (includingtheendosteum) (Figure4J).Thus,asubset
of the earliest Osx-CreERt-expressing cells represent precursors
of the osteoblast pool populating the primary ossification center.
Osx-Expressing Precursors Give Rise to the Full
Differentiation Spectrum of Osteoblast Lineage
Cells inside the Growing Bone but Also Include
Pericyte-like Cells
Histological and EM analysis at E16.5 showed that the Osx/
LacZ+ cells presented as peritrabecular stromal cells, cuboidal
osteoblasts covering the trabecular bone surfaces, endosteal
osteoblasts, and osteocytes entrapped within the bone (Fig-
ures 5A–5C). Many, albeit not all, of the Osx/LacZ+ cells now
expressed endogenous Col1 mRNA, as detected by in situ
hybridization (ISH) (Figure 5B). Of note, all Col1/LacZ+ cells
expressed Col1 mRNA (not shown). Thus, these tracing studies
revealed that the earliest Osx-CreERt-expressing cells, or at
least a subset of them, gave rise to the full differentiation spec-
trum of osteoblast lineage cells inside the growing bone, and
therefore represent true precursors of trabecular osteoblasts.
Analyzing the environment of the Osx/LacZ+ cells at E16.5, we
noted that they often resided in close proximity to blood vessels
inside themarrowcavity (Figure 5D). Somecells that hadbecome
mature cuboidal osteoblasts displayed a prominent polarity with
bone matrix on the apical side, lateral neighboring osteoblasts,
and blood vessels flanking the basal surface. Sometimes endo-Figure 5. Perichondrial Osx/LacZ+ Cells Include Osteoblast Precursors
the Developing Bone, and Pericytic Cells
(A–C) Perichondrial Osx-CreERt-expressing osteoblast precursors labeled at E12
stromal cells, and cortical osteocytes by E16.5. Overview sections are shown on t
ISH (red signal, overlaid onto contrast or Hoechst images). Arrowheads, Osx/La
hypertrophic cartilage. Areas (1) and (2) as from boxes in the overview image; a
and EM views of the red boxed areas (1–4, as localized in the overview section
the parallel EM image by a blue ‘‘+’’. Bottom, magnified views; note cytoplasmic
(D) Frequent proximity of cuboidal Osx/LacZ+ osteoblasts on mineralized bone (
region (white box in (C)) and areas analyzed by EM in (D) (1–2) and (E) (3). Bo
Note vessels running directly adjacent to Osx/LacZ+ osteoblasts (left panels), o
Osx/LacZ+ (red arrow) (right panels).
(E and F) Pericytic localization of Osx/LacZ+ cells revealed by EM (E) and PECAM-
of vessels into the diaphysis. Arrowheads, tight junctions between ECs; inset and
overview and magnifications of a section stained by X-gal, PECAM-1 (brown), an
also Figure S5, providing molecular characterization of Osx-expressing cells usin
Developthelial cells were immediately adjacent to the osteoblasts, while
in other cases stretched perivascular cells were seen in between
(Figure 5D). Some of these perivascular cells were, in fact, Osx/
LacZ+ cells juxtaposed to the endothelium like pericytes (Figures
5D–5F). Such cells displayed a morphology characteristic of
undifferentiated cells, with a very prominent nucleus, a small
cell body with long and thin processes and sparse granular ER,
Golgi apparatus, and organelles. Like pericytes, their cell
processes closely enfolded the endothelial lining of the vessel
(Figure 5E). Immunohistochemistry (IHC) for the endothelial
cell-specific marker platelet/endothelial cell adhesion molecule
1 (PECAM-1) indicated that Osx/LacZ+ cells were abundantly
found in theseperivascular locations (Figure 5F). Thus, in addition
to giving rise to bone-forming osteoblasts in the primary spon-
giosa, a fraction of the embryonic osteoblast precursors charac-
terizedbyOsxexpression retains an immature identity andaperi-
cytic localization during bone development.
To address the molecular characteristics of Osx-expressing
cells, we took advantage of the Osx-Cre:GFP mouse model
(Rodda and McMahon, 2006) to allow GFP-based cell sorting
(designated as Osx/GFP+ cells) and visual colocalization studies
(red fluorescent IHC and ISH) (Figure S5). The same BAC was
used to generate both the Osx-Cre:GFP and the Osx-CreERt
mice, and the Cre:GFP expression correlates with endogenous
Osx mRNA expression and with Osx-CreERt-labeling in terms
of pattern and timing in developing bones (see Figures S4 and
S5). Like traced Osx/LacZ+ cells, Osx/GFP+ populations
encompassed cells of a wide osteoblast differentiation spectrum
including non-collagen type I- and osteopontin-expressing
immature cells; their genetic profile indicated strong enrichment
in Osx- and Runx2-expression (Figures S5A–S5D). Osx/GFP+
cells too could regularly be found in immediate perivascular
locations, even in adult bones (Figure S5E). Osx/GFP+ perivas-
cular cells did, however, not fully cover the vascular bed but
were rather found scattered on some of the blood vessels. Since
qRT-PCR revealed the presence of transcripts for several peri-
cyte markers (RGS5, SM22, and desmin; data not shown) in
Osx/GFP+ sorted cell samples, we assessed the potential coloc-
alization of Osx/GFP+ or Osx/LacZ+ cells and pericyte markers
in bone sections (Figures S5F–S5I). While a-smoothmuscle actin
(aSMA), SM22, desmin, and Nerve/Glial antigen 2 (NG2) were
indeed detected in a few Osx-expressing cells, the functional
significance of their presence is, however, unclear: none of the
markers’ expression patterns tracked that of the vascular patternthat Give Rise to Stromal Cells, Osteoblasts, and Osteocytes inside
.5 give rise to endosteal osteoblasts (OBs), trabecular OBs and peritrabecular
he right. (A) Histology with magnifications in insets. Scale bar, 200 mm. (B) Col1
cZ+ cells expressing Col1 mRNA; arrows, Col1-negative Osx/LacZ+ cells; hc,
rea (3) shows a cortex detail. (C) EM analysis by aligned toluidine blue, LacZ
on the right) with indication of Osx/LacZ+ cells, identified by blue staining, on
X-gal deposits in these LacZ+ cells.
‘‘+’’ and arrowheads) to RBC-containing blood vessels (V). Top, outline of the
ttom, histology by (left) eosin or (right) additional PECAM-1 staining (brown).
r separated only by spindle-shaped perivascular cells (asterisk), some being
1 IHC (F). (E) Overview and increasingmagnifications of area 3 (see D), entry site
arrow, overlapping cellular extensions of the subendothelial coverage. (F) Top,
d eosin. Bottom, detailed views of perivascular-located Osx/LacZ+ cells. See
g the Osx-Cre:GFP mouse model.
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Figure 6. Entry of Osteoblast Precursors into Developing Bones Correlates with Their Colocalization to the Cartilage-Invading Vasculature
(A and B) Longitudinal sections stained by eosin or TRAP (A, bottom), showingOsx/LacZ+ cells colocalizing with vessels (V, containing RBCs [intensemagenta on
eosin]) and osteoclasts (arrows) at the time of their accumulation in the middiaphyseal perichondrium just prior to invasion of hypertrophic cartilage (HC) (A) and
during the invasion (B).
(C) Analysis of the initial HC invasion process using thin transverse, middiaphyseal sections. Abbreviations: V, vessel; HC, hypertrophic cartilage; EC, endothelial
cell; RBC, redbloodcell; blue ‘‘+’’,Osx/LacZ+cell;OCL, osteoclast. (C1) X-gal view (top) identifyingOsx/LacZ+cells and (below) alignedEM imagescorresponding
to theblackboxeson the left and right, respectively. Furthermagnifications from the respectivewhite boxes are shownbeloweachpanel. Note initiation of cartilage
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Hence, the vasculature inside embryonic and adult bones is
unusual in that it largely lacks classical pericyte coverage.
Coinvasion of Osteoblast Precursors and Blood Vessels
into Developing Long Bones
The finding that Osx/LacZ+ cells anatomically resembling peri-
cytes were observed both at the time of their initial labeling in
the perichondrium and after their tracing to the inside of the
bone raised the question whether the perivascular localization
of Osx/LacZ+ cells was a consistent feature. We therefore
examined the spatial relationship between the Osx/LacZ+ cells
and the vasculature throughout cartilage invasion.
Osx/LacZ+ cells closely colocalized with blood vessels and
osteoclasts as they accumulated in the perichondrium just prior
to the invasion of the hypertrophic cartilage (Figure 6A), as well
as during initial invasion (Figure 6B). Osx/LacZ+ cells were de-
tected alongside the vessels and at the angiogenic front (Figures
6A–6C,1). Capillaries traversed through openings in the bone
collar and entered the hypertrophic cartilage core as perfused
vessels (filled with RBCs) (Figure 6C,2) interspersed with Osx/
LacZ+ cells (Figure 6C,3). The initial vascular invasion process
and formation of a primary ossification center did not depend
on the presence osteoclasts (Figure S6).
A pulse-chase analysis employing PECAM-1 staining revealed
the persistence of the osteoblast precursor/endothelium juxta-
position throughout the subsequent stages of cartilage excava-
tion, culminating in the establishment of the primary ossification
center by E15.5–E16.0 (Figure 6D, left panels). Although Osx/
LacZ+ cells were regularly wrapped around the blood vessels,
they were never observed inside the lumen. In sharp contrast
to the Osx/LacZ+ precursor cells, Col1/LacZ+ mature osteo-
blasts showed little or no evidence of association with the
invading vasculature (Figure 6D, right). These findings indicate
that the time of entry of osteoblast precursors into developing
bones is intimately related to their invasion by blood vessels,
suggesting the possibility of a coupled movement process
involving mechanisms that are specific to early cells in the
osteoblast lineage and lost upon advanced osteoblastic
differentiation.
Coupled Angiogenesis and Osteogenesis in Healing
Fractures Is Associated with Entry of Osx-Expressing,
Blood Vessel-Associated Osteoblast Precursors
Given that the processes governing embryonic bone develop-
ment are largely recapitulated during fracture healing, we
wondered whether a similar coinvasion of osteoblast lineage
cells and blood vessels may occur in the adult setting of bone
repair. After confirming that the Osx/GFP+ cells in Osx-Cre:GFP
mice showed a coinvasion with blood vessels into the devel-
oping primary ossification center similar to that observed with
the Osx-CreERt mice (Figure 7A), we employed the Osx-
Cre:GFP mouse line to allow direct visualization of the predom-invasionwith bone-collar-transversing ECs displaying abundant filopodia extensio
of a RBC-filled vessel transversing the bone collar (dotted line). (C3) RBC-filled ca
(D) PECAM-1 stained Osx-CreERt and Col1-CreERt humeri at the indicated time
(A)–(D), Col1-CreERt mice received 4OHTam at E13.5.
See Figure S6 on the role of osteoclasts in initial invasion.
Developinantly nuclear GFP signal by confocal microscopy of thick bone
sections.
Adult (3-month-old) Osx-Cre:GFP mice showed the presence
of Osx/GFP-expressing cells in the thin periosteal layer over-
laying the cortical bone surface of uninjured bones (postfracture
day [PFD] 0) (Figure S7A). We next monitored the relationship
between Osx/GFP+ cells and PECAM-1+ endothelium (red fluo-
rescent IHC) during the subsequent stages of the endochondral
healing process in a semistabilized fracture model applied
to Osx-Cre:GFP mice (schematically depicted in Figure S7B).
As observed previously, the induction of a bone defect is asso-
ciated with an early proliferative response in the periosteum
of the disrupted cortices (Maes et al., 2006). Osx-GFP+ cells
were particularly abundant in this thickened periosteum at PFD
4 (Figure S7C). Further dynamic studies indicated that by PFD
14, Osx/GFP+ cells contributed massively to the woven bone
callus, localizing within the regenerating bone regions as well
as along the blood vessels interspersing the woven bone
(Figure S7D).
Interestingly, during the endochondral ossification process
occurring in the interim time, the infiltration of the cartilaginous
callus tissues by invading endothelium was closely associated
with coinvasion of Osx-GFP+ cells (PFD 7, Figure 7B). Adult
Osx/GFP+ cells were markedly abundant in the vascularized
peripheral portion of the callus bordering the cartilage and along
the invasion fronts. Confocal microscopy revealed pericyte-like
Osx/GFP+ cells surrounding the endothelium of the extending
vascular plexus (Figure 7B; Movies S1–S4). These data suggest
that similar mechanisms might govern the coinvasion of osteo-
blast precursors and blood vessels in bone development and
fracture healing.
To address the relationship between osteoblast precursors
and the vasculature at the molecular level, we performed
qRT-PCR analysis on FACS-sorted Osx-expressing cells as
compared with cell preparations without selection for Osx
expression (see Supplemental Experimental Procedures). Osx/
GFP+ cell digests showed 3- to 10-fold increased expression
levels of VEGF and angiopoietin-1 (Ang1), factors secreted by
pericytes that may mediate their recruitment of endothelial cells
(Figure 7C). Moreover, the expression of the PDGF receptor
PDGF-Rb, a crucial receptor for recruitment of pericytes to
endothelium, was also detected in Osx/GFP+ cells, suggestive
of a molecular cross-talk between the colocalizing cell types
(Figure 7C).
DISCUSSION
The Perichondrial Origin of Trabecular Osteoblasts
The origin of the osteogenic stroma and the osteoblasts that
occupy the primary ossification center to form trabecular bone
has been uncertain. Hypotheses have suggested that these
cells derive from the perichondrium/periosteum, from chondro-
cytes, from delivery of circulating progenitors through the bloodns (red arrows), indicative of sprouting angiogenesis. (C2) Toluidine blue picture
pillaries budding into the cartilage, interspersed with Osx/LacZ+ cells.
points. Osx-CreERt embryos were exposed to 4OHTam at E12.5 or E13.5 in
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Figure 7. Simultaneous Osteoblastic and Angiogenic Invasion of Cartilage in Healing Fractures
(A) PECAM-1 IHC on frozen E15.5 Osx-Cre:GFP tibia sections revealing Osx/GFP+ cells (green, note predominant nuclear localization of the Cre:GFP fusion
protein) and endothelium (red) during the initial invasion of the hypertrophic cartilage (HC) and primary ossification center (POC) formation. PC, perichondrium.
Right, magnified views of indicated areas.
(B) Thick section analysis of fractured tibia of Osx-Cre:GFPmice at postfracture day (PFD) 7, stained with PECAM-1 antibodies (red) and Hoechst (blue). Top row,
overview of the callus at 53 by standard microscopy (left; yellow, vasculature; dark areas, cartilage [c] and cortical bone [b]; p, periosteum) indicating the areas
(boxes 1–3) analyzed by confocal microscopy. Right panels, areas 1 and 2, showing projections of sets of stacked images taken with a 203 objective (also see
Movies S1–S3). Bottom left, area 3, showing 3D projection of 603 confocal images (also see Movie S4). The 3D red channel (PECAM-1 signal) is also shown
separately (black/white view), revealing the endothelial filopodia at the invasion front (red arrows). Bottom right, single optical slice extracted from the 603 stack,
and enlarged detail omitting the blue channel signal for optimal appreciation of the Osx/GFP+ nuclei. Note abundant Osx/GFP+ cells immediately juxtaposing the
endothelial lining (arrowheads) and tips at the invasion front (arrows).
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Figure 8. Model Summarizing Our Findings
Schematic outline of the events taking place during the initial invasion of the
cartilaginous bone model and its transformation into the primary ossification
center (POC). Col2-expressing chondro-perichondrial progenitors (green)
give rise to cells in the central growth cartilage and to transversally oriented
cells at the periphery with presumed perichondrial/osteoblastic fates. The first
committed osteoblast lineage cells appear in the perichondrium surrounding
the middiaphyseal hypertrophic cartilage. The cells display differential desti-
nies in the developing bone depending on their stage of maturation. Early cells
of the lineage, represented by the Osx-expressing osteoblast precursors (Osx/
LacZ+, yellow), move into the developing POC and populate it as stromal cells
or differentiate further to become bone-forming trabecular osteoblasts. The
entrance of the osteoblast precursors into the POC coincides with the initial
invasion by blood vessels (red) and osteoclasts (blue), and is associated
with a pericytic localization of a subset of the precursors onto the endothelium.
In contrast, cells that differentiated to the stage of Col1 (3.2 kb) expression
within the perichondrium/periosteum (Col1/LacZ+ mature osteoblasts,
orange) are not found in vessel-covering positions and do not have the
capacity to translocate into the POC. These osteoblasts are retained on and
within the cortical bone surfaces.
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1994; Kronenberg, 2007; Modder and Khosla, 2008; Roach and
Erenpreisa, 1996). Here, we assessed the fate of osteoblast
lineage cells from the embryonic perichondrium. Our results
confirm and extend previous ex vivo findings by Colnot et al.
(2004), who showed that perichondrial cells of unidentified
genetic signature contribute osteoblasts to developing bones
planted under the renal capsule. By using the mouse Osx- and
Col1-promoters to drive the expression of the inducible CreERt
transgene in stage-selective subsets of perichondrial osteo-
blast-lineage cells, we now find that osteoblast precursors, as
opposed to mature perichondrial osteoblasts, have the capacity
to enter the developing bone and differentiate there into trabec-
ular osteoblasts (see Figure 8). This does not necessarily imply
that the sole fate of all the labeled Osx/LacZ+ cells is to become
mature osteoblasts. In fact, our data indicate that a subset of
them contributes to the metaphyseal stroma, displaying a rather
undifferentiated phenotype (see Figures 5A–5C). It is unclear(C) qRT-PCR analysis of VEGF, Ang1, and PDGFRb in Osx/GFP+ sorted cell popu
bones from newborn Osx-Cre:GFP mice, as compared with control digests of Os
the stacked confocal images and data on other time points during the fracture h
Developwhether such cells constitute reserve precursors that can be
activated later to become osteoblasts. Alternatively, and not
mutually exclusively, they may represent a subpopulation with
different/independent fates and functions, such as hematopoi-
etic support (Wu et al., 2008).
Differentiated Chondrocytes Are Not a Major Source
of Trabecular Osteoblasts
Since the initially labeled Col1/LacZ+ cells were confined to the
perichondrium, whereas Osx/LacZ+ cells additionally included
differentiating chondrocytes, we assessed whether the latter
may have constituted or contributed to the trabecular osteoblast
pool. Our data using an inducible Col2-CreERt confirm that early
in development, Col2-expressing cells include bipotent progen-
itors contributing to the chondrocyte and osteoblast pools in
endochondral bones (Hilton et al., 2007; Nakamura et al.,
2006; Sakai et al., 2001) (Figure S3). Even later on, cells at the
periphery of the growth cartilage particularly, exhibiting a longitu-
dinal arrangement along the cartilage-perichondrium interface
(‘‘borderline chondrocytes’’) (Bianco et al., 1998), may become
incorporated in the perichondrium and/or give rise to osteoblasts
at the endosteum and inside the bone. In contrast, our data
outlined in Figure 3 indicate that Col2/LacZ+ cells that join the
bulk of the more central growth cartilage, where they follow the
classical chondrocyte differentiation program toward hyper-
trophy, do not become trabecular osteoblasts in the central
metaphyseal regions (away from the endosteal surfaces) in the
time span of our studies.
Coinvasion of Cartilage by Osteoblast Precursors
and Blood Vessels
Several prior experiments have probed the interdependence of
vascular and osteoblastic invasion of bone. Blocking the initial
vascular invasion of the cartilage template, either physically,
chemically, or genetically, inhibited the formation of the primary
ossification center (Colnot et al., 2004; Maes et al., 2002). On the
other hand, several genetic models involving an early block
in perichondrial osteoblastogenesis through inactivation of
Runx2, Osx, b-catenin, or Indian hedgehog also showed a
near-complete absence of vascular invasion and primary ossifi-
cation (Komori et al., 1997; Otto et al., 1997; Colnot et al., 2005;
St. Jacques et al., 1999; Nakashima et al., 2002; Hill et al., 2005).
Collectively, these studies suggest that perichondrial osteoblast
differentiation, at least up to the stage of Runx2/Osx-expressing
precursors, is required for vascular invasion of cartilage. In con-
trast, blockade of osteoclast formation genetically or through
inhibitors of osteoclastogenesis (Figure S6) does not block inva-
sion of either blood vessels or osteoblasts.
In our study, the two processes could be analyzed closely in
a cell-specific way by combining osteoblast lineage tracing
with monitoring of the vascular endothelium. Throughout the
translocation of osteoblast precursors from the perichondrium
into the nascent primary ossification center, several osteoblast
lineage cells were seen to intimately associate with the invadinglations (mean ± SEM; n = 4) derived from collagenase-digested calvaria or long
x-Cre:GFP-negative littermates (‘‘whole lysate’’). Video files (Movies S1–S4) of
ealing process are provided in Figure S7.
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a coupled movement process that appears to be recapitulated
during bone regeneration of fractures (see Figures 6D, 7A,
and 7B).
Based on our data and current literature, three hypotheses for
the coupling can be formulated. First, osteoblast precursors and
endothelial cells may be attracted to the same or simultaneously
expressed chemoattractant(s) produced by the hypertrophic
cartilage, thereby moving in concert into its core. However,
mere independent comigration would not explain the pericytic
localization that we recognized for a portion of the osteoblast
precursors during the movement process.
Therefore, a second mechanism may be that some osteoblast
precursors use the blood vessels as a conduit to support their
entry into the bone, as reported for melanoma tumor cells that
migrate along the abluminal surface of the endothelium in a
process termed ‘‘extravascular migratory metastasis’’ (Lugassy
et al., 2004). Our studies indicated that Osx-expressing cells
strongly express angiogenic stimuli as well as molecules
involved in pericyte-endothelial interactions (VEGF, Ang1,
PDGRb). Of note, it is uncertain whether the perivascular osteo-
blast lineage cells detected in our study have functional charac-
teristics generally attributed to pericytes. In fact, different from
most other tissues, the blood vessels of bone lacked coverage
by supporting cells expressing classical pericyte markers such
as aSMA (see Figures S5F–S5H). This observation may be
related to the presence in bonemarrow of thin-walled and fenes-
trated sinusoids, in which trans-endothelial migration of hemato-
poietic cells is thought to take place (Kopp et al., 2005).
A third option is that osteoblast precursors themselves trigger
the initial vascular invasion, by pulling vessels into the avascular
cartilage. This may involve ‘‘looping angiogenesis,’’ a recently
proposed mechanism describing the vascularization of previ-
ously avascular, contracting granulation tissue of healing
wounds through biomechanical translocation of intact vessels
as loops pulled by myofibroblastic contraction (Kilarski et al.,
2009). Our EM analyses revealed that capillaries invade the
cartilage as morphologically intact vessels that are presumably
connected to the circulation, as evidenced by the abundance
of RBCs in their lumens, with osteoblast precursors locating
to the leading edges as well as along the lumen linings (see
Figure 6C). The expansion of the vascular plexus most likely
involves sprouting angiogenesis, as suggested by the abundant
filopodia extending from the endothelial cells at the tips of the
invading vascular sprouts, observed by EM and (confocal)
histology (indicated by red arrows in Figure 6C1 during initial
cartilage invasion in embryogenesis and in Figure 7B3 andMovie
S4, showing a 3D projection of callus neovascularization during
endochondral bone healing). Endothelial tip cells are known to
display characteristically high expression of PDGF-B and
VEGFR-2 (Gerhardt et al., 2003), possibly implicating a cross-
talk with the PDGFRb- and VEGF-enriched osteoblast lineage
cells.
These three hypotheses are not mutually exclusive and may
converge in the following model (see Figure 8): Osteoblast
precursors developing in the perichondrium invade the future
marrow space along with blood vessels, both while in associa-
tion with the endothelium in pericytic fashion and by migrating
along with the front of sprouting vessels and osteoclasts exca-342 Developmental Cell 19, 329–344, August 17, 2010 ª2010 Elsevievating the cartilage. Osteoblast precursor interactions with the
endothelium may contribute to the translocation into the late-
hypertrophic cartilage, possibly through combined mechanisms
of looping and sprouting angiogenesis, that may be directionally
steered by the high concentration and release of stimulatory
signals such as VEGF. Osteoblasts that had differentiated into
mature, matrix-producing cells in the perichondrium do not
have pericyte properties, nor do they move into the bone and
become trabecular osteoblasts. Instead, these cells are destined
to generate the cortical bone.EXPERIMENTAL PROCEDURES
Animal Studies
The generation of Osx-CreERt2 andCol1(3.2 kb)-CreERt mice is outlined in the
Supplemental Experimental Procedures. Osx-Cre:GFP mice have been
described (Rodda and McMahon, 2006). Experiments were conducted in
compliance with the Guide for the Care and Use of Laboratory Animals and
approved byMassachusetts General Hospital’s Center for Comparative Medi-
cine and by the K.U.Leuven. Male CreERt(Tg/);Rosa26R(R/R) mice were
timed mated to CD1 females overnight and separated in the morning, desig-
nated E0.5. Pregnant mice received 2 mg 4OHTam i.p. (50mg/kg), dissolved
stepwise in 20 ml dimethylfluoride and to a total volume of 200 ml in sunflower
seed oil. At sacrifice, the embryos were weighed and dissected clear of skin
and internal organs. Tail or liver biopsies were collected for genotyping by
PCR (see Supplemental Experimental Procedures). Skeletal muscles were
removed from the limbs from E15.5 onward. Selected embryos were stained
with Alizarin red using the standard protocol. Fracture healing was studied in
3-month-old Osx-Cre:GFP mice using a semistabilized tibia fracture model
described in detail before (Maes et al., 2006). The tibia was fixed overnight
in 2% PFA and decalcified in 0.5M EDTA for 2 weeks.
X-Gal Staining of LacZ Activity
The embryo proper as well as the organs and separated limbs were fixed for
1 hr at RT in 0.2% glutaraldehyde and 1.5% formaldehyde, followed by over-
night X-gal staining at 37C according to the standard protocol, and 1 day
postfixation in 2% PFA at 4C.
Histology
X-gal-stained samples were paraffin embedded and sectioned at 4 mm. When
necessary, bones were decalcified for 1–3 days prior to the embedding.
Sections were dewaxed in xylenes, immersed stepwise in 100% and 95%
ethanol, and stained with 1% eosinY in 95% ethanol for 5 min followed by
rinsing, dehydrating, and mounting. Von Kossa staining was done according
to standard methods and followed by eosin staining. Additional sections
were subjected to staining for TRAP activity or to IHC using antibodies for
PECAM-1 (CD31) (BD Biosciences) or BrdU (Harlan Sera-Lab) as described
(Maes et al., 2002). Detailed information on IHC and ISH procedures for oste-
oblast and pericyte markers is provided in the Supplemental Experimental
Procedures. Fracture calluses were studied using thick sections preserving
the Osx/GFP+ signal, by embedding the bones in 5% low melting seaplaque
agarose (Lonza Rockland) and sectioning at 100 mm on a Microm Vibratome.
Sections were stained with PECAM-1 antibodies (Cy3 red fluorescent detec-
tion) and Hoechst dye (blue nuclear signal).
Imaging
Whole-mount images were captured on a Leica MZ16 stereomicroscope
equipped with Image-Pro Plus digital imaging module. Histological sections
were imaged on Nikon Eclipse E800 and Zeiss Axioplan microscopes using
23, 43, 103, 203, 403, and 1003 objectives, and SPOT Advanced or Axio-
vision software. Whole-image adjustments of brightness and contrast were
done using Adobe Photoshop software. Thick vibratome sections were
analyzed on a Nikon Eclipse Ti-2000 inverse confocal scanning microscope
using 0.75 N.A. 203 and 1.4 N.A. 603 (oil) objectives to acquire image stacks
and single confocal optical slices using NIS-Elements AR3.1 software.r Inc.
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composed with the ImageJ program (version 1.42).
Quantification of LacZ-Positive Cells
Perichondrial labeling was quantified on E14.5 humerus sections by counting
the number of LacZ+ and LacZ+/BrdU+ double-positive cells in a fixed area
(spanning 345 mm longitudinally, centralized at the middiaphysis) comprising
most of the perichondrium (shown in Figure 2A, left). Three to five sections
were analyzed per bone (n = 3 per genotype), including only central-cut
sections at least 40 mm apart. The proliferation index was calculated as
the percentage LacZ+/BrdU+ cells of the total LacZ+ cell count. At E16.5,
LacZ+ cells were counted in defined (210 3 210 mm) regions of the trabecular
and cortical bone areas, positioned centrally along perpendicular axes through
the bone, as indicated in Figure 2A (right, blue squares). Trabecular regions
were taken 50 mm distal of the hypertrophic chondrocyte zone to exclude
the junction. Three to five sections per bone of n = 2–9 embryoswere analyzed,
blindly with regard to genotype. Statistical analysis was done by two-sided,
two-sample t tests. Results are represented as average ± SEM, with the
symbols * for p < 0.05, **p < 0.01, and ***p < 0.001.
EM Analysis
After X-gal staining, bones were cleared completely of surrounding soft
tissues, cut transversally at middiaphysis, fixed in EM fixative (2.5% glutaral-
dehyde, 2.0% PFA, 0.025% calcium chloride in a 0.1 M sodium cacodylate
buffer [pH 7.4]), and processed for EM. The samples were embedded vertically
(E13.5–E14.5) or horizontally (E16.5) in resin, to create transversal or longitu-
dinal sections, respectively. Three sets of consecutive sections were
prepared, as illustrated in Figure 4A: (1) 1 mm sections stained with toluidine
blue for 15 s to visualize the tissue morphology, (2) 0.3 mm sections that
were placed on top of grids for EM analysis, and 3) 1 mm sections that
remained unstained to visualize the blue LacZ+ cells. Aligning the information
from the respective sections allowed for a cell-specific analysis of the labeled
cells as inspected by EM. The correct identification of each of the labeled cells
via this procedure was confirmed by the recognition on EM of X-gal reaction
product deposits in the cytoplasm of LacZ+ cells, as patchy distributed black
amorphous material, in several of the analyzed samples. Samples were exam-
ined with a Phillips 301 transmission electron microscope and digital images
were captured using an AMT (Advanced Microscopy Techniques) CCD
camera at magnifications ranging from 34500 to 319,500. Quantifications
were done by classifying the LacZ+ cells based on their morphology and
spatial characteristics: pericytic cells, displaying immediate perivascular local-
ization; stromal cells, displaying no connection to bone matrix and having little
ER and few organelles; early osteoblast lineage cells, located in the proximity
or onto collagen matrix but still containing limited ER, sparse plasma
membrane convolutions and no or sparse evidence of secretion activity;
mature osteoblasts, defined as cuboidal cells located on osteoid and/or miner-
alized bone and actively secreting matrix; osteocytes, cells immediately
flanked by bone matrix on at least three sides.
FACS Sorting, RNA Extraction, and Gene Expression Analysis
by qRT-PCR
The preparation of calvaria and long bone digests from newborn Osx-Cre:GFP
mice, their FACS sorting, and qRT-PCR analysis are described in detail in the
Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and four movies and can be found online at doi:10.1016/
j.devcel.2010.07.010.
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